Firm
Firms in Canada explain how they’ve adapted to a rule change in 2017 that has made advocacy skills more important in pharma disputes
Leaders at some IP businesses are looking to consolidate the fragmented market and, considering the benefits, their rivals may want to follow suit
Counsel at three US firms explain how they are expanding their UPC teams or if they are looking to partner with European firms
Lucy Wheatley, partner at McGuireWoods, discusses the challenges of explaining trademarks to a jury and reveals a logistical hurdle she had to navigate
Sponsored
Sponsored
-
Sponsored by Liu Shen & AssociatesGuanyang Yao and Zhifei An of Liu Shen & Associates provide an analysis of IP cases decided by China’s Supreme Court and consider the characteristics of each -
Sponsored by Chang Tsi & PartnersMichael Wu of Chang Tsi & Partners explains why Chinese enterprises dealing with SEP litigation should respond actively to ensure the issue is litigated before the Chinese courts
-
Sponsored by Wanhuida Intellectual PropertyThe China Patent Office upheld the validity of the patent over the antihistamine desloratadine citrate disodium, as Yue Guan from Wanhuida Intellectual Property explains
-
Sponsored by Patrinos & KilimirisYouli Angelou of Patrinos & Kilimiris explains why the consolidation of all branches of industrial property is a welcome move
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S discusses a technical board of appeal referral that deals with the issue of entitlement to priority
-
Sponsored by Remfry & SagarShukadev Khuraijam and Ankush Verma of Remfry & Sagar discuss pre-grant straw man oppositions in India and the impact of a recent decision of the Bombay High Court
